Bortezomib-based consolidation or maintenance therapy for multiple myeloma: a meta-analysis

Volume: 10, Issue: 3
Published: Mar 6, 2020
Abstract
Bortezomib-based regimens are widely used as induction therapy for multiple myeloma (MM). Unlike lenalidomide, the role of bortezomib in consolidation and maintenance therapy for MM is less clear. We performed a meta-analysis to evaluate the impact of bortezomib-based consolidation and maintenance therapy on survival outcomes and adverse events. PubMed, Web of Science, Embase databases, and major conference proceedings were searched for...
Paper Details
Title
Bortezomib-based consolidation or maintenance therapy for multiple myeloma: a meta-analysis
Published Date
Mar 6, 2020
Volume
10
Issue
3
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.